SUN-255 PATRO Children, a Multi-Center, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment: Comparing United States (US) and Rest of World (ROW) Data

Lignende værker

• Design of, and first data from, PATRO Children, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(®) in children requiring growth hormone treatment
  af: Pfäffle, Roland, et al.
  Udgivet: (2013)
• SAT-437 The Patro Adults Study of Omnitrope® for the Treatment of Adult Patients with Growth Hormone Deficiency: Latest Safety Outcomes Including Diabetes Risk
  af: Beck-Peccoz, Paolo, et al.
  Udgivet: (2019)
• Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope(®)): data from the PATRO Adults study
  af: Beck-Peccoz, Paolo, et al.
  Udgivet: (2020)
• SUN-254 A Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human Growth Hormone (rhGH), in Short Children Born Small for Gestational Age (SGA)
  af: Schwarz, Hans-Peter, et al.
  Udgivet: (2019)
• Ten years with biosimilar rhGH in clinical practice in Sweden – experience from the prospective PATRO children and adult studies
  af: Lundberg, Elena, et al.
  Udgivet: (2020)